← Eichor
Study identifier: NCT06191198 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Communication Bridge 3 Study

Condition: Primary Progressive Aphasia  ·  Sponsor: University of Chicago

PhasePhase 2
Planned participants200
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.

This description comes directly from the study's public registry record.

Talk to the study team

Matthew Bona, MPH  ·  773-702-1220  ·  cbtrial@uchicago.edu

Emily Cummings  ·  773-702-1221  ·  cbtrial@uchicago.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Chicago - American School BuildingChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06191198